Samantha L. Lagace, PA

Samantha Lagace practices at Erie VA Medical Center in Erie, Pennsylvania, part of Veterans Health Administration.

Samantha Lagace's NPI, 1790073724, was assigned on July 12, 2011. Samantha Lagace holds New York license 014851.

Samantha Lagace's primary practice is Erie VA Medical Center, at 135 East 38th Street, Erie, PA 16504 in Erie County. The practice phone is (814) 860-2576.

Samantha Lagace's primary practice is Erie VA Medical Center in Erie, Pennsylvania, part of Veterans Health Administration. The medical group on file is Schweiger Dermatology Group. Dmand AI also links Samantha Lagace to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Samantha Lagace practices, 2 sites in all. Vendor and product names are available with a free account.

Physician assistant is Samantha Lagace's primary specialty in the NPI Registry, under taxonomy code 363A00000X. Samantha Lagace is board certified in certified physician assistant by the National Commission on Certification of Physician Assistants (NCCPA). Samantha Lagace is licensed in New York.

Dmand AI lists acute skin infection, anxiety, benign or precancerous skin growths, cold sores or genital herpes, contact dermatitis, itchy rashes, minor head injury and minor injury to a limb among the conditions Samantha Lagace treats.

CMS data shows 2,715 Medicare services from Samantha Lagace across 18 procedure codes in 2024, for 471 Medicare patients. Medicare paid $79,718 for them. Every service was in an office.

CMS counts 471 Medicare patients who saw Samantha Lagace in 2024. The largest group is 65 to 74, with 234 patients. 75% of them have high cholesterol, and 66% have high blood pressure. 5% are also on Medicaid. Their average risk score is 0.81, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Samantha Lagace's median patient age at 62, with 64% women.

In 2024, Samantha Lagace wrote 1,082 Medicare Part D claims for 374 patients. 81% of them were for generic drugs. CMS names the drug for 916 of them, across 15 drugs with 11 or more claims each, at $557,012 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Samantha Lagace for performance year 2024, reported individually. Samantha Lagace accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 91 general payments to Samantha Lagace from 18 drug and device companies in 2025. Food and beverage make up the largest share, 100% of the total. Abbvie Inc. paid the most, $366.